-
1
-
-
52149093835
-
The metabolic syndrome and the risk of arterial and venous thrombosis
-
Franchini M, Targher G, Montagnana M, Lippi G. The metabolic syndrome and the risk of arterial and venous thrombosis. Thromb Res 2008; 122:727–35.
-
(2008)
Thromb Res
, vol.122
, pp. 727-735
-
-
Franchini, M.1
Targher, G.2
Montagnana, M.3
Lippi, G.4
-
2
-
-
33645288292
-
Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes
-
Trost S, Pratley R, Sobel B. Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes. Curr Diab Rep 2006; 6:47–54.
-
(2006)
Curr Diab Rep
, vol.6
, pp. 47-54
-
-
Trost, S.1
Pratley, R.2
Sobel, B.3
-
3
-
-
77949468819
-
The association of tumor necrosis factor α receptor 2 and tumor necrosis factor α with insulin resistance and the influence of adipose tissue biomarkers in humans
-
Hivert MF, Sullivan LM, Shrader P, Fox CS, Nathan DM, D'Agostino RB Sr, et al. The association of tumor necrosis factor α receptor 2 and tumor necrosis factor α with insulin resistance and the influence of adipose tissue biomarkers in humans. Metabolism 2010; 59:540–6.
-
(2010)
Metabolism
, vol.59
, pp. 540-546
-
-
Hivert, M.F.1
Sullivan, L.M.2
Shrader, P.3
Fox, C.S.4
Nathan, D.M.5
D'agostino, R.B.6
-
5
-
-
38549101510
-
Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: A comprehensive meta-review
-
Mina A, Favaloro EJ, Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Semin Thromb Hemost 2009; 35:798–809.
-
(2009)
Semin Thromb Hemost
, vol.35
, pp. 798-809
-
-
Mina, A.1
Favaloro, E.J.2
Koutts, J.3
-
6
-
-
44949088433
-
Metabolic syndrome, haemostasis and thrombosis
-
Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008; 99:995–1000.
-
(2008)
Thromb Haemost
, vol.99
, pp. 995-1000
-
-
Alessi, M.C.1
Juhan-Vague, I.2
-
7
-
-
44849093847
-
Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk
-
Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28:1039–49.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 1039-1049
-
-
Després, J.P.1
Lemieux, I.2
Bergeron, J.3
Pibarot, P.4
Mathieu, P.5
Larose, E.6
-
8
-
-
33846264060
-
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: The plot thickens
-
Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007; 24:1–6.
-
(2007)
Diabet Med
, vol.24
, pp. 1-6
-
-
Targher, G.1
-
9
-
-
77951183828
-
A preliminary study of inflammatory markers in non-alcoholic steatohepatitis patients
-
Priya MT, Sheriff DS. A preliminary study of inflammatory markers in non-alcoholic steatohepatitis patients. Libyan J Med 2010; 5:5071.
-
(2010)
Libyan J Med
, vol.5
, pp. 5071
-
-
Priya, M.T.1
Sheriff, D.S.2
-
10
-
-
67649170396
-
Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome
-
Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin Thromb Hemost 2009; 35:277–87.
-
(2009)
Semin Thromb Hemost
, vol.35
, pp. 277-287
-
-
Targher, G.1
Chonchol, M.2
Miele, L.3
Zoppini, G.4
Pichiri, I.5
Muggeo, M.6
-
11
-
-
0037126526
-
NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report
-
Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106:3143–421.
-
(2002)
Circulation
, vol.106
, pp. 3143-3421
-
-
-
12
-
-
0037027467
-
Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus
-
Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002; 106:2442–7.
-
(2002)
Circulation
, vol.106
, pp. 2442-2447
-
-
Diamant, M.1
Nieuwland, R.2
Pablo, R.F.3
Sturk, A.4
Smit, J.W.5
Radder, J.K.6
-
13
-
-
57349096045
-
The metabolic syndrome
-
Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008; 29:777–822.
-
(2008)
Endocr Rev
, vol.29
, pp. 777-822
-
-
Cornier, M.A.1
Dabelea, D.2
Hernandez, T.L.3
Lindstrom, R.C.4
Steig, A.J.5
Stob, N.R.6
-
14
-
-
0348230958
-
Obesity is associated with macrophage accumulation in adipose tissue
-
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796–808.
-
(2003)
J Clin Invest
, vol.112
, pp. 1796-1808
-
-
Weisberg, S.P.1
McCann, D.2
Desai, M.3
Rosenbaum, M.4
Leibel, R.L.5
Ferrante, A.W.6
-
16
-
-
33646178955
-
Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms
-
Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113:1888–904.
-
(2006)
Circulation
, vol.113
, pp. 1888-1904
-
-
Kim, J.A.1
Montagnani, M.2
Koh, K.K.3
Quon, M.J.4
-
18
-
-
44449109670
-
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men
-
Targher G, Bertolini L, Rodella S, Lippi G, Franchini M, Zoppini G, et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity 2008; 16:1394–9.
-
(2008)
Obesity
, vol.16
, pp. 1394-1399
-
-
Targher, G.1
Bertolini, L.2
Rodella, S.3
Lippi, G.4
Franchini, M.5
Zoppini, G.6
-
19
-
-
0142137406
-
Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome
-
Aubert H, Frere C, Aillaud MF, Morange PE, Juhan-Vague I, Alessi MC. Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome. J Thromb Haemost 2003; 1:791–7.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 791-797
-
-
Aubert, H.1
Frere, C.2
Aillaud, M.F.3
Morange, P.E.4
Juhan-Vague, I.5
Alessi, M.C.6
-
20
-
-
0347632946
-
Weight loss reduces tissue factor in morbidly obese patients
-
Kopp CW, Kopp HP, Steiner S, Kriwanek S, Krzyzanowska K, Bartok A, et al. Weight loss reduces tissue factor in morbidly obese patients. Obes Res 2003; 11:950–6.
-
(2003)
Obes Res
, vol.11
, pp. 950-956
-
-
Kopp, C.W.1
Kopp, H.P.2
Steiner, S.3
Kriwanek, S.4
Krzyzanowska, K.5
Bartok, A.6
-
21
-
-
0036123456
-
Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease
-
Mills JD, Mansfield MW, Grant PJ. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease. Thromb Haemost 2002; 87:409–14.
-
(2002)
Thromb Haemost
, vol.87
, pp. 409-414
-
-
Mills, J.D.1
Mansfield, M.W.2
Grant, P.J.3
-
22
-
-
0035512784
-
Relationship between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals. Role of adipose tissue
-
Targher G, Bonadonna RC, Alberiche M, Zenere MB, Muggeo M, Bonora E. Relationship between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals. Role of adipose tissue. Diabetes Care 2001; 24:1961–6.
-
(2001)
Diabetes Care
, vol.24
, pp. 1961-1966
-
-
Targher, G.1
Bonadonna, R.C.2
Alberiche, M.3
Zenere, M.B.4
Muggeo, M.5
Bonora, E.6
-
23
-
-
77951456827
-
Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very low density lipoprotein – apolipoprotein B100 in obesity
-
Chan DC, Watts GF, Sengkhee D, Wong ATY, Ooi EMM, Hugh P, et al. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very low density lipoprotein – apolipoprotein B100 in obesity. Clinical and population studies. Arterio Thromb Vas Biol 2010; 30:1043–50.
-
(2010)
Clinical and Population Studies. Arterio Thromb Vas Biol
, vol.30
, pp. 1043-1050
-
-
Chan, D.C.1
Watts, G.F.2
Sengkhee, D.3
Wong, A.T.Y.4
Ooi, E.M.M.5
Hugh, P.6
-
24
-
-
0034966562
-
Plasma levels of free and total TFPI, relationship with cardiovascular risk actors and endothelial cell markers
-
Morange PE, Renucci JF, Charles MA, Aillaud MF, Giraud F, Grimaux M, et al. Plasma levels of free and total TFPI, relationship with cardiovascular risk actors and endothelial cell markers. Thromb Haemost 2001; 85:999–1003.
-
(2001)
Thromb Haemost
, vol.85
, pp. 999-1003
-
-
Morange, P.E.1
Renucci, J.F.2
Charles, M.A.3
Aillaud, M.F.4
Giraud, F.5
Grimaux, M.6
-
25
-
-
0037382786
-
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
-
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37:917–23.
-
(2003)
Hepatology
, vol.37
, pp. 917-923
-
-
Marchesini, G.1
Bugianesi, E.2
Forlani, G.3
Cerrelli, F.4
Lenzi, M.5
Manini, R.6
-
26
-
-
10744221675
-
The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: Prospective data from the Verona Diabetes Complications Study
-
Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabet Med 2004; 21:52–8.
-
(2004)
Diabet Med
, vol.21
, pp. 52-58
-
-
Bonora, E.1
Targher, G.2
Formentini, G.3
Calcaterra, F.4
Lombardi, S.5
Marini, F.6
|